These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 1285314)
1. Plasmodium falciparum CS protein--prime malaria vaccine candidate: definition of the human CTL domain and analysis of its variation. Doolan DL; Good MF Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():241-7. PubMed ID: 1285314 [TBL] [Abstract][Full Text] [Related]
2. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2. Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214 [TBL] [Abstract][Full Text] [Related]
3. Cytotoxic T lymphocyte (CTL) low-responsiveness to the Plasmodium falciparum circumsporozoite protein in naturally-exposed endemic populations: analysis of human CTL response to most known variants. Doolan DL; Khamboonruang C; Beck HP; Houghten RA; Good MF Int Immunol; 1993 Jan; 5(1):37-46. PubMed ID: 7680226 [TBL] [Abstract][Full Text] [Related]
4. Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. Malik A; Egan JE; Houghten RA; Sadoff JC; Hoffman SL Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3300-4. PubMed ID: 1707538 [TBL] [Abstract][Full Text] [Related]
5. Location of human cytotoxic T cell epitopes within a polymorphic domain of the Plasmodium falciparum circumsporozoite protein. Doolan DL; Houghten RA; Good MF Int Immunol; 1991 Jun; 3(6):511-6. PubMed ID: 1716144 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T lymphocytes to Plasmodium falciparum epitopes in an area of intense and perennial transmission in Tanzania. Lalvani A; Hurt N; Aidoo M; Kibatala P; Tanner M; Hill AV Eur J Immunol; 1996 Apr; 26(4):773-9. PubMed ID: 8625967 [TBL] [Abstract][Full Text] [Related]
7. Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development. Doolan DL; Saul AJ; Good MF Infect Immun; 1992 Feb; 60(2):675-82. PubMed ID: 1730503 [TBL] [Abstract][Full Text] [Related]
8. Antigenic diversity in the circumsporozoite protein of Plasmodium falciparum abrogates cytotoxic-T-cell recognition. Udhayakumar V; Shi YP; Kumar S; Jue DL; Wohlhueter RM; Lal AA Infect Immun; 1994 Apr; 62(4):1410-3. PubMed ID: 7510668 [TBL] [Abstract][Full Text] [Related]
9. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers. Wizel B; Houghten R; Church P; Tine JA; Lanar DE; Gordon DM; Ballou WR; Sette A; Hoffman SL J Immunol; 1995 Jul; 155(2):766-75. PubMed ID: 7541824 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T cell reactivity and HLA-B35 binding of the variant Plasmodium falciparum circumsporozoite protein CD8+ CTL epitope in naturally exposed Kenyan adults. Udhayakumar V; Ongecha JM; Shi YP; Aidoo M; Orago AS; Oloo AJ; Hawley WA; Nahlen BL; Hoffman SL; Weiss WR; Lal AA Eur J Immunol; 1997 Aug; 27(8):1952-7. PubMed ID: 9295031 [TBL] [Abstract][Full Text] [Related]
11. Identification of a nonameric H-2Kk-restricted CD8+ cytotoxic T lymphocyte epitope on the Plasmodium falciparum circumsporozoite protein. Malik A; Houghten R; Corradin G; Buus S; Berzofsky JA; Hoffman SL Infect Immun; 1995 May; 63(5):1955-9. PubMed ID: 7537251 [TBL] [Abstract][Full Text] [Related]
12. T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites. Nardin E; Munesinghe YD; Moreno A; Clavijo P; Calle MC; Edelman R; Davis J; Herrington D; Nussenzweig RS Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():223-7. PubMed ID: 1364202 [TBL] [Abstract][Full Text] [Related]
13. Low CD8+ T lymphocyte response to P. falciparum circumsporozoite protein in naturally-exposed malaria endemic populations in Thailand. Khusmith S; Tangteerawatana P; Looareesuwan S Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):405-11. PubMed ID: 10774643 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3. Aidoo M; Lalvani A; Gilbert SC; Hu JT; Daubersies P; Hurt N; Whittle HC; Druihle P; Hill AV Infect Immun; 2000 Jan; 68(1):227-32. PubMed ID: 10603392 [TBL] [Abstract][Full Text] [Related]
15. Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein. Moreno A; Clavijo P; Edelman R; Davis J; Sztein M; Herrington D; Nardin E Int Immunol; 1991 Oct; 3(10):997-1003. PubMed ID: 1721837 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum. Kumar S; Miller LH; Quakyi IA; Keister DB; Houghten RA; Maloy WL; Moss B; Berzofsky JA; Good MF Nature; 1988 Jul; 334(6179):258-60. PubMed ID: 2456467 [TBL] [Abstract][Full Text] [Related]
17. Immunization with soluble protein-pulsed spleen cells induces class I-restricted cytotoxic T lymphocytes that recognize immunodominant epitopic peptides from Plasmodium falciparum and HIV-1. Hosmalin A; Kumar S; Barnd D; Houghten R; Smith GE; Hughes SH; Berzofsky JA J Immunol; 1992 Aug; 149(4):1311-8. PubMed ID: 1380039 [TBL] [Abstract][Full Text] [Related]
18. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa. DobaƱo C; Doolan DL Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242 [TBL] [Abstract][Full Text] [Related]
19. T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides. Widmann C; Romero P; Maryanski JL; Corradin G; Valmori D J Immunol Methods; 1992 Oct; 155(1):95-9. PubMed ID: 1383348 [TBL] [Abstract][Full Text] [Related]
20. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Aidoo M; Lalvani A; Allsopp CE; Plebanski M; Meisner SJ; Krausa P; Browning M; Morris-Jones S; Gotch F; Fidock DA Lancet; 1995 Apr; 345(8956):1003-7. PubMed ID: 7536870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]